Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from Pediatric Endocrinology of North Texas - Episode 3
Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care
Audience polls provide the panel insights into common screening practices for patients with type 1 diabetes.
The following is a summary of the video transcript and has been edited for length and clarity.
Dr Goldman posed the following questions to the live audience. They are included here for your consideration when thinking about the approach to type 1 diabetes screening and staging in your practice.
To whom do you usually refer patients for confirmation of progression from Stage 2 to Stage 3 T1D and specialized management?
A. Endocrinologist
B. Pediatric endocrinologist
C. Immunologist
D. Diabetes specialist nurse
E. None, I don’t have the resources to refer
F. Other
How frequently do you screen primary populations for Type 1 diabetes stage progression during a routine appointment?
A. Always
B. Often
C. Occasionally
D. Rarely
E. Never
Why do you think screening for progression through T1D stages is important?
A. To detect early signs of disease progression and intervene
B. To tailor treatment strategies based on the stage of T1D advancement
C. To mitigate the risk of long-term complications specific to advanced T1D stages
D. All of the above
E. Other
How do you typically screen primary populations for T1D risk factors during routine appointments?
A. Laboratory tests for autoantibodies
B. Oral glucose tolerance test (OGTT)
C. Clinical assessment of symptoms and risk factors
D. Combination of the above
E. Other
